MedCity News December 22, 2024
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the company’s Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach.
This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor.
The company added generative AI to its Stelo glucose monitor, which it began selling four months ago. The device is an over-the-counter glucose biosensor that empowers people — both those with and without diabetes — to actively track their metabolic health.
Adding generative AI to this glucose monitor will help the device better analyze users’ health data patterns,...
Today's Sponsors
Today's Sponsor